RE:Bottom?This is a research and development company. If they are not breaking through like they did before last week then i would say based on its operations i don't see this going up to .80 or 1 dollar anytime soon. I don't think it will bleed out, but my understanding of research companies is that they require funds to complete their research. Based on the recent non-brokered private placement of up to 12,500,000 units at a price of .40 per unit for gross proceeds of up to $5mil, this will help escalate their research in their new findings. If they are to be successful it will look like every company out there are going to jump on this company to buy it out and take their research. The research does seem to be farfetched because up until this day we have yet to find a cure for cancer. Getting it from cannbinoid seems very rare and unlikely. It's been around for quite some time. However, the inhibitors is what seems to be interesting and breaking through to the media.